Skip to content

Clinical trials

Completed Carcinoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Status: Completed Country / region: Netherlands Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20051
20063
20071
20081
20093
20112
20123
20141
20162
20171
20193
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Bayer2
Steba Biotech S.A.2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Ariad Pharmaceuticals1
Cook Group Incorporated1
Daiichi Sankyo1
GlaxoSmithKline1
Hoffmann-La Roche1
Hookipa Biotech GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma25
Neoplasms12
Neoplasms by Site5
Adenocarcinoma4
Carcinoma, Renal Cell4
Lung Neoplasms4
Neuroendocrine Tumors4
Carcinoid Tumor3
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.